SNTI - Senti Biosciences, Inc.
0.9649
0.027 2.777%
Share volume: 150,605
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$0.94
0.03
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-14-2024 | 03-20-2025 | 05-06-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 16.301 M | 13.356 M | 14.902 M | 16.167 M | 16.397 M | 16.948 M | |
| Selling general and admin | 7.522 M | 4.205 M | 6.247 M | 8.396 M | 7.116 M | 6.432 M | |
| Research and development | 8.779 M | 9.151 M | 8.655 M | 7.771 M | 9.281 M | 10.516 M | |
| Total expenses | 16.301 M | 13.356 M | 15.215 M | 16.167 M | 16.397 M | 16.948 M | |
| -18.07% | 13.92% | 6.26% | 1.42% | 3.36% | |||
| Operating income | -16.301 M | -13.356 M | -15.215 M | -16.167 M | -16.397 M | -16.948 M | |
| Ebit | -16.301 M | -11.439 M | -29.016 M | -841.000 K | -14.506 M | -18.292 M | |
| Pretax income | -12.111 M | -11.203 M | -28.866 M | -610.000 K | -14.112 M | -18.126 M | |
| -7.50% | 157.66% | -97.89% | 2,213.44% | 28.44% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -12.111 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | |||||||
| Net income | -12.111 M | -11.203 M | -28.866 M | -610.000 K | -14.112 M | -18.126 M | |
| 7.50% | -157.66% | 97.89% | -2,213.44% | -28.44% |